$ABBV (+0.13%) AbbVie (NYSE: ABBV) reported fourth quarter EPS of $2.16, $0.10 more than the analyst estimate of $2.06.
Revenue for the quarter totaled $15.1B, compared to the average estimate of $14.82B.
Forecast
In fiscal 2025, AbbVie expects EPS of $12.12-$12.32. Analysts had expected an average of $12.13.